Efficacy and Safety of Tolvaptan in Subjects With Chronic Kidney Disease Between Late Stage 2 to Early Stage 4 Due to Autosomal Dominant Polycystic Kidney Disease
Clinical trial NCT02160145 · COMPLETED
Trial details
- NCT number
- NCT02160145
- Sponsor
- Otsuka Pharmaceutical Development & Commercialization, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2014-05-01
- Primary completion
- 2017-04-18
- Enrollment
- 1370
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.